Literature DB >> 3919174

Effect of stimulus intensity on the profile of anticonvulsant activity of phenytoin, ethosuximide and valproate.

S G Piredda, J H Woodhead, E A Swinyard.   

Abstract

The relative ability of phenytoin, ethosuximide and valproate to prevent minimal (clonic) threshold, maximal (tonic extension of the hindlimbs) threshold and supramaximal (tonic extension of the hindlimbs) seizures elicited by electrical and chemical (Metrazol, bicuculline, and picrotoxin) stimulation was determined. Ethosuximide and valproate were effective against minimal (clonic) threshold seizures, whereas phenytoin was ineffective and even activated them. All three anticonvulsants were effective against maximal (tonic extension of the hindlimbs) threshold seizures. Phenytoin and valproate, but not ethosuximide, were effective against supramaximal (tonic extension of the hindlimbs) seizures. The results suggest that the specificity of experimental models of epilepsy used in the evaluation of potential antiepileptic drugs is primarily due to the intensity rather than the nature of the stimulus used or the kind of seizure component evoked. Models based only on maximal (tonic extension of the hindlimbs) threshold seizures may identify anticonvulsant activity, but do not differentiate between substances that prevent seizure spread and those that increase seizure threshold.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919174

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

Review 1.  Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.

Authors:  Melissa Barker-Haliski; H Steve White
Journal:  Neuropharmacology       Date:  2019-08-27       Impact factor: 5.250

2.  GABAergic modulation of inferior colliculus excitability: role in the ethanol withdrawal audiogenic seizures.

Authors:  G D Frye; T J McCown; G R Breese; S L Peterson
Journal:  J Pharmacol Exp Ther       Date:  1986-05       Impact factor: 4.030

3.  NBI-921352, a first-in-class, NaV1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats.

Authors:  J P Johnson; Thilo Focken; Kuldip Khakh; Parisa Karimi Tari; Celine Dube; Samuel J Goodchild; Jean-Christophe Andrez; Girish Bankar; David Bogucki; Kristen Burford; Elaine Chang; Sultan Chowdhury; Richard Dean; Gina de Boer; Shannon Decker; Christoph Dehnhardt; Mandy Feng; Wei Gong; Michael Grimwood; Abid Hasan; Angela Hussainkhel; Qi Jia; Stephanie Lee; Jenny Li; Sophia Lin; Andrea Lindgren; Verner Lofstrand; Janette Mezeyova; Rostam Namdari; Karen Nelkenbrecher; Noah Gregory Shuart; Luis Sojo; Shaoyi Sun; Matthew Taron; Matthew Waldbrook; Diana Weeratunge; Steven Wesolowski; Aaron Williams; Michael Wilson; Zhiwei Xie; Rhena Yoo; Clint Young; Alla Zenova; Wei Zhang; Alison J Cutts; Robin P Sherrington; Simon N Pimstone; Raymond Winquist; Charles J Cohen; James R Empfield
Journal:  Elife       Date:  2022-03-02       Impact factor: 8.140

4.  Continuous seizure emergency evoked in mice with pharmacological, electrographic, and pathological features distinct from status epilepticus.

Authors:  Kevin M Knox; Dannielle K Zierath; H Steve White; Melissa Barker-Haliski
Journal:  Epilepsia       Date:  2021-10-08       Impact factor: 5.864

5.  Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations.

Authors:  Michael C Smith; Pavel Klein; Gregory L Krauss; Samiya Rashid; Lawrence G Seiden; John M Stern; William E Rosenfeld
Journal:  Neurol Ther       Date:  2022-09-03

Review 6.  The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models.

Authors:  H S White; M Johnson; H H Wolf; H J Kupferberg
Journal:  Ital J Neurol Sci       Date:  1995 Feb-Mar

Review 7.  Strategies for identifying and developing new anticonvulsant drugs.

Authors:  H J Kupferberg
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

8.  Loss of presenilin 2 age-dependently alters susceptibility to acute seizures and kindling acquisition.

Authors:  Megan Beckman; Kevin Knox; Zachery Koneval; Carole Smith; Suman Jayadev; Melissa Barker-Haliski
Journal:  Neurobiol Dis       Date:  2019-12-17       Impact factor: 5.996

9.  Small-molecule anticonvulsant agents with potent in vitro neuroprotection and favorable drug-like properties.

Authors:  Garry R Smith; Douglas E Brenneman; Yan Zhang; Yanming Du; Allen B Reitz
Journal:  J Mol Neurosci       Date:  2013-11-26       Impact factor: 3.444

Review 10.  Alzheimer's Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation.

Authors:  Leanne Lehmann; Alexandria Lo; Kevin M Knox; Melissa Barker-Haliski
Journal:  Neurochem Res       Date:  2021-04-30       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.